Lancet Capital

What is Lancet Capital?

Lancet Capital is a private equity venture capital firm committed to empowering scientists and entrepreneurs with the goal of commercializing their innovations in the biomedical field.

Established in 1998, and with its headquarters at 654 Madison Avenue, 9th Floor, New York, New York, Lancet has carved a niche for itself by specializing in early-stage investments in bio-informatics, biopharmaceuticals, biomedical technologies, medical devices, medical information systems, medical therapeutics, and diagnostic systems.

The firm is strategically positioned in the healthcare sector, focusing on BioTech, Medical Devices & Hospital Services, Healthcare & Wellness, and Life Sciences, thereby playing a vital role in advancing meaningful innovations that can significantly contribute to the wellbeing of communities and the health sector at large.

With a notable expertise in equity investments, Lancet Capital has set a minimum investment threshold of $2,000,000 and can invest up to $4,000,000 in a single venture.

Having assets under management totaling $220,000,000, the firm has considerable resources to support the growth and expansion of early-stage companies. The firm distinguishes itself by not just providing capital, but also by offering value-adding services such as supplying startup senior management, expertise in startup operations, business planning, recruitment of management, and granting access to key resources and expertise.

These comprehensive services are reflective of Lancet Capital's commitment to nurturing the next generation of biomedical solutions and its dedication to contributing to the success of the ventures it invests in.